(MENAFN- ProactiveInvestors) With a rally of up to 60% at one point Karelian Diamond Resources () glistened as Friday’s top riser after it discovered diamonds in eastern Finland.
The discovery was described by Karelian as a ‘major step’ towards unearthing a world class deposit.
() meanwhile advanced around 20% on Friday as the Department of Energy & Climate change agreed to extend licence boundaries to add another gas discovery to the group’s portfolio.
Parkmead and were among the small cap North Sea stocks rising after Wednesday’s budget which threw North Sea firms a lifeline.
Technology investor () meanwhile rose 25% as its part-owned associate Motif BioSciences confirmed it will float on AIM this month.
Prior to the IPO Amphion owns 38% of the clinical stage biopharma group which is developing antibiotics to treat infections caused by multi-drug resistant bacteria.
There were other medical sector successes this week as Sphere () advanced around 20% as it launched its Proxima blood analysis device in mainland Europe with the Netherlands Belgium and Germany firmly in the company’s sights.
Deltex Medical () was boosted as three directors bought shares and it revealed a study that validated a combination of Deltex’s oesophageal Doppler monitoring (ODM) blood flow system with heart rate monitoring; its product performed the best out of nine combinations.
In the technology and media sector () shares were in demand as its full-year results were well received. The mobile marketing and payments group showed revenue pre-tax profit and cash generation all moving in the right direction thanks to a strong performance in the UK.
Mirada () the ‘audiovisual interaction’ specialist hired former Disney and Electronic Arts (EA) exec Gonzalo Babio as its new chief financial officer.
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.